Cardinal Health Outlines Leadership Succession Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil gains after Trump says US will hit Iran 'very hard tonight'
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Cardinal Health (CAH) PT Lowered to $67 at Jefferies; Remains Sidelined
November 7, 2017 8:10 AM ESTJefferies lowered its price target on Cardinal Health (NYSE: CAH) to $67.00 (from $77.00) while maintaining a Hold rating following the company's earnings release. Despite missing consensus revenue by ~2.5% ($32.6B vs. $33.4B), CAH beat on earnings for the quarter as a result of better than expected... More
